Author: ellaturner

The “C3 Glomerulopathy: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment... Read More

The “Epstein-Barr Virus Disease (EBR): Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for... Read More

The “Hypoactive Sexual Desire Disorder: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for... Read More

Over the last two decades, medical researchers have been able to achieve proof-of-concept and demonstrate the viability of benefits of mRNA-based interventions. In fact, currently, there are more than 65... Read More

The “Global Pharmaceutical Vials Market - Distribution by Type of Fabrication Material Used (Glass and Plastic), Sterilization Status (Pre-sterilized and Unsterilized) and Key Geographies (North America, Europe, Asia Pacific, Latin... Read More

The “PERK Inhibitor: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment... Read More

The “TIGIT Inhibitor: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment... Read More

The “Duchenne Muscular Dystrophy: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the... Read More

The “Peripheral T-cell Lymphoma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the... Read More

Over the years, clinical research has undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. It is worth highlighting that clinical research... Read More